co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcino.引用肝脏血管而不是在肝细胞癌血管生成驱动器获得性耐索拉非尼
本文档由 pubmed001 分享于2016-12-20 15:37
co-option of liver vessels and not sprouting angiogenesis drives acquired sorafenib resistance in hepatocellular carcino.引用肝脏血管而不是在肝细胞癌血管生成驱动器获得性耐索拉非尼
分享:
君,已阅读到文档的结尾了呢~~